Scientists at Tel Aviv and Ben Gurion Universities have found that an important cell-maintenance process called “autophagy” is reduced in the brains of schizophrenic patients due to low levels of the protein beclin 1. Medication to boost beclin 1 levels could offer a new way to treat schizophrenia.
http://www.aftau.org/site/News2?page=NewsArticle&id=19583&news_iv_ctrl=-1